Skip to main content

Advertisement

Log in

Predictive value of combining the level of fibrinogen and CHA2DS2-VASC Score for contrast-induced acute kidney injury in patients with acute coronary syndromes undergoing percutaneous coronary intervention

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

The present study aimed to investigate the value of preprocedural fibrinogen (FIB) combined with CHA2DS2-VASC scores in the risk prediction of contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS).

Method

A total of 934 patients (mean age 63.9 ± 11.5 years, and 32.1% female), who were admitted to our hospital for ACS and underwent PCI, were retrospectively enrolled. The patients were divided into two groups: non-CI-AKI group (n = 787) and CI-AKI group (n = 147). Contrast-induced acute kidney injury was defined as an increase of ≥ 0.5 mg/dL or ≥ 25% serum creatinine within 48–72 h after PCI. Spearman correlation analysis was used to determine the relationship between FIB and CHA2DS2-VASC scores.

Results

Patients with high baseline FIB levels and high CHA2DS2-VASC scores had higher CI-AKI incidence. On spearman correlation analysis, FIB and CHA2DS2-VASC scores were positively correlated (R = 0.236, P < 0.001). The ROC statistical analysis showed that the combination had 63.3% sensitivity with 72.6% specificity for the development of CI-AKI (area under the curve: 0.727, 95% CI 0.697–0.755, P < 0.001). A total of 934 ACS patients were divided into low-risk group (404 cases), medium-risk group (383 cases) and high-risk group (147 cases) according to the cut-off values of FIB and CHA2DS2-VASC scores. The incidence of CI-AKI was higher in the high-risk group than in the low-risk and medium-risk groups (Log-rank χ2 = 104.505, 56.647. P < 0.001). Multivariate analysis revealed that albumin (OR = 0.913, 95% CI 0.867–0.962), FIB (OR = 1.451, 95% CI 1.185–1.77), CHA2DS2-VASC score (OR = 1.271, 95% CI 1.504–1.78) were the independent risk factors of CI-AKI (p < 0.05).

Conclusion

The preprocedural fibrinogen combined with CHA2DS2-VASC score is independently associated with the risk of CI-AKI in ACS patients treated by PCI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The data used to support the findings of this study can be obtained from the corresponding author.

References

  1. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105(19):2259–2264. https://doi.org/10.1161/01.cir.0000016043.87291.33

    Article  PubMed  Google Scholar 

  2. Lazaros G, Tsiachris D, Tousoulis D, Patialiakas A, Dimitriadis K, Roussos D et al (2012) In-hospital worsening renal function is an independent predictor of one-year mortality in patients with acute myocardial infarction. Int J Cardiol 155(1):97–101. https://doi.org/10.1016/j.ijcard.2010.10.024

    Article  PubMed  Google Scholar 

  3. Mehran R, Dangas GD, Weisbord SD (2019) Contrast-associated acute kidney injury. N Engl J Med 380(22):2146–2155. https://doi.org/10.1056/NEJMra1805256

    Article  CAS  PubMed  Google Scholar 

  4. Narula A, Mehran R, Weisz G, Dangas GD, Yu J, Genereux P et al (2014) Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J 35(23):1533–1540. https://doi.org/10.1093/eurheartj/ehu063

    Article  CAS  PubMed  Google Scholar 

  5. Lun Z, Liu L, Chen G, Ying M, Liu J, Wang B et al (2021) The global incidence and mortality of contrast-associated acute kidney injury following coronary angiography: a meta-analysis of 1.2 million patients. J Nephrol 34(5):1479–1489. https://doi.org/10.1007/s40620-021-01021-1

    Article  PubMed  PubMed Central  Google Scholar 

  6. Senoo T, Motohiro M, Kamihata H, Yamamoto S, Isono T, Manabe K et al (2010) Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 105(5):624–628. https://doi.org/10.1016/j.amjcard.2009.10.044

    Article  PubMed  Google Scholar 

  7. Gurm HS, Seth M, Kooiman J, Share D (2013) A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 61(22):2242–2248. https://doi.org/10.1016/j.jacc.2013.03.026

    Article  PubMed  Google Scholar 

  8. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44(7):1393–1399. https://doi.org/10.1016/j.jacc.2004.06.068

    Article  PubMed  Google Scholar 

  9. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME et al (2014) Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc 3(6):e001380

    Article  Google Scholar 

  10. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB et al (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294(14):1799–1809. https://doi.org/10.1001/jama.294.14.1799

    Article  CAS  PubMed  Google Scholar 

  11. Mosesson MW (2010) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3(8):1894–1904

    Article  Google Scholar 

  12. Wang Y, Sun W-J, Ji Z-S, Liu C-B, Wang R (2020) Serum albumin and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention. Rev Cardiovasc Med 21(1):139–145. https://doi.org/10.31083/j.rcm.2020.01.583

    Article  PubMed  Google Scholar 

  13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Annl Intern Med 130(6):461–470. https://doi.org/10.7326/0003-4819-130-6-199903160-00002

    Article  CAS  Google Scholar 

  14. Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ (2014) Canadian association of radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J 65(2):96–105. https://doi.org/10.1016/j.carj.2012.11.002

    Article  PubMed  Google Scholar 

  15. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845

    Article  CAS  Google Scholar 

  16. Haq MFU, Yip CS, Arora P (2020) The conundrum of contrast-induced acute kidney injury. J Thorac Dis 12(4):1721–1727. https://doi.org/10.21037/jtd.2019.12.88

    Article  PubMed  PubMed Central  Google Scholar 

  17. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF et al (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial The Iohexol Cooperative Study. Kidney Int 47(1):254–261. https://doi.org/10.1038/ki.1995.32

    Article  CAS  PubMed  Google Scholar 

  18. Kusirisin P, Chattipakorn SC, Chattipakorn N (2020) Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med 18(1):400. https://doi.org/10.1186/s12967-020-02574-8

    Article  PubMed  PubMed Central  Google Scholar 

  19. Vlachopanos G, Schizas D, Hasemaki N, Georgalis A (2019) Pathophysiology of contrast-induced acute kidney injury (CIAKI). Curr Pharm Des 25(44):4642–4647. https://doi.org/10.2174/1381612825666191210152944

    Article  CAS  PubMed  Google Scholar 

  20. Gao F, Zhou YJ, Zhu X, Wang ZJ, Yang SW, Shen H (2011) C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Am J Nephrol 34(3):203–210. https://doi.org/10.1159/000329534

    Article  CAS  PubMed  Google Scholar 

  21. Ang L, Behnamfar O, Palakodeti S, Lin F, Pourdjabbar A, Patel MP et al (2017) Elevated baseline serum fibrinogen: effect on 2-year major adverse cardiovascular events following percutaneous coronary intervention. J Am Heart Assoc. https://doi.org/10.1161/JAHA.117.006580

    Article  PubMed  PubMed Central  Google Scholar 

  22. Li M, Tang C, Luo E, Qin Y, Wang D, Yan G (2020) Relation of fibrinogen-to-albumin ratio to severity of coronary artery disease and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Biomed Res Int 2020:1860268. https://doi.org/10.1155/2020/1860268

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zheng L, Wang Z, Liu J, Yang X, Zhang S, Hao Z et al (2021) Association between admission blood fibrinogen-to-albumin ratio and clinical outcomes after acute lacunar stroke. Biomark Med 15(2):87–96. https://doi.org/10.2217/bmm-2019-0537

    Article  CAS  PubMed  Google Scholar 

  24. Sorensen I, Susnik N, Inhester T, Degen JL, Melk A, Haller H, Schmitt R (2011) Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int 80(10):1035–1044. https://doi.org/10.1038/ki.2011.214

    Article  CAS  PubMed  Google Scholar 

  25. Celik IE, Kurtul A, Duran M, Yarlioglues M, Elcik D, Kilic A et al (2016) Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome. Coron Artery Dis 27(1):13–18. https://doi.org/10.1097/mca.0000000000000295

    Article  PubMed  Google Scholar 

  26. Murat SN, Kurtul A, Yarlioglues M (2015) Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention. Angiology 66(8):732–737. https://doi.org/10.1177/0003319714551979

    Article  CAS  PubMed  Google Scholar 

  27. Vanmassenhove J, Kielstein J, Jörres A, Biesen WV (2017) Management of patients at risk of acute kidney injury. The Lancet 389(10084):2139–2151. https://doi.org/10.1016/s0140-6736(17)31329-6

    Article  Google Scholar 

  28. Capodanno D, Rossini R, Musumeci G, Lettieri C, Senni M, Valsecchi O et al (2015) Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. Int J Cardiol 199:319–325. https://doi.org/10.1016/j.ijcard.2015.07.064

    Article  PubMed  Google Scholar 

  29. Unal S, Acar B, Yayla C, Balci MM, Ertem A, Kara M et al (2016) Importance and usage of the CHA2DS2-VASc score in predicting acute stent thrombosis. Coron Artery Dis 27(6):478–482. https://doi.org/10.1097/MCA.0000000000000388

    Article  PubMed  Google Scholar 

  30. Chou RH, Huang PH, Hsu CY, Leu HB, Huang SS, Huang CC et al (2016) CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions. J Formos Med Assoc 115(7):501–509. https://doi.org/10.1016/j.jfma.2015.12.008

    Article  PubMed  Google Scholar 

  31. Wang Y, Zhao HW, Zhang XJ, Chen BJ, Yu GN, Hou AJ, Luan B (2019) CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience. BMC Cardiovasc Disord 19(1):74. https://doi.org/10.1186/s12872-019-1060-0

    Article  PubMed  PubMed Central  Google Scholar 

  32. Verma BR, Williams B, Honushefsky A, Kaur S, Doddamani S (2016) The albumin globulin ratio in chronic heart failure—implications for mortality. J Cardiac Fail 22(8):S30

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wenhua Li.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Wang, Z., Zhang, B. et al. Predictive value of combining the level of fibrinogen and CHA2DS2-VASC Score for contrast-induced acute kidney injury in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Int Urol Nephrol 54, 2385–2392 (2022). https://doi.org/10.1007/s11255-022-03149-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-022-03149-w

Keywords

Navigation